Literature DB >> 12011009

Role of tumor necrosis factor alpha in Helicobacter pylori gastritis in tumor necrosis factor receptor 1-deficient mice.

Ulrike Thalmaier1, Norbert Lehn, Klaus Pfeffer, Manfred Stolte, Michael Vieth, Wulf Schneider-Brachert.   

Abstract

Increased gastric production of interleukin 8 and tumor necrosis factor alpha (TNF-alpha) has been implicated in the pathogenesis of Helicobacter pylori-associated gastroduodenal disease. In the present study we used a mouse model to demonstrate whether loss of the tumor necrosis factor receptor 1 (TNF-R1) function leads to differences in gastric inflammation or the systemic immune response in H. pylori infection. Six different clinical isolates of H. pylori (three cytotoxin-positive and three cytotoxin-negative strains) were adapted to C57BL/6 mice. TNF-R1-deficient (TNF-R1(-/-)) mice (n = 19) and isogenetic controls (n = 24) were infected and sacrificed after 4 weeks of infection. Inflammation of the stomach and the humoral immune response to H. pylori were evaluated by histological, immunohistochemical, and serological methods. There was no detectable difference in the grade or activity of gastritis in TNF-R1(-/-) mice when they were compared with wild-type mice, but the number of lymphoid aggregates was slightly reduced in the gastric mucosa of TNF-R1(-/-) mice. Interestingly, total immunoglobulin G (IgG), as well as IgG1, IgG2b, and IgG3, H. pylori-specific antibody titers were significantly higher in wild-type mice. As revealed by immunoblot analysis, the difference in reactivity against H. pylori antigens was not based on a failure to recognize single H. pylori antigens in TNF-R1(-/-) mice. We therefore suggest that TNF-R1-mediated TNF-alpha signals might support a systemic humoral immune response against H. pylori and that the gastric inflammatory response to H. pylori infection seems to be independent of TNF-R1-mediated signals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011009      PMCID: PMC127975          DOI: 10.1128/IAI.70.6.3149-3155.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

2.  Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice.

Authors:  L E Smythies; K B Waites; J R Lindsey; P R Harris; P Ghiara; P D Smith
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  The effect of Helicobacter pylori on cell proliferation and apoptosis in gastric epithelial cell lines.

Authors:  A Takagi; S Watanabe; M Igarashi; J Koike; K Hasumi; R Deguchi; Y Koga; T Miwa
Journal:  Aliment Pharmacol Ther       Date:  2000-04       Impact factor: 8.171

4.  Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor.

Authors:  M Pasparakis; L Alexopoulou; M Grell; K Pfizenmaier; H Bluethmann; G Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models.

Authors:  K A Eaton; D Kersulyte; M Mefford; S J Danon; S Krakowka; D E Berg
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Helicobacter pylori infection in interleukin-4-deficient and transgenic mice.

Authors:  W Chen; D Shu; V S Chadwick
Journal:  Scand J Gastroenterol       Date:  1999-10       Impact factor: 2.423

7.  Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice.

Authors:  T Aebischer; S Laforsch; R Hurwitz; F Brombacher; T F Meyer
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  Lack of gastritis and of an adaptive immune response in interferon regulatory factor-1-deficient mice infected with Helicobacter pylori.

Authors:  F Sommer; G Faller; M Röllinghoff; T Kirchner; T W Mak; M Lohoff
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

9.  Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants.

Authors:  A E Kamradt; M Greiner; P Ghiara; S H Kaufmann
Journal:  Microbes Infect       Date:  2000-05       Impact factor: 2.700

10.  Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling.

Authors:  B Lucas; D Bumann; A Walduck; J Koesling; L Develioglu; T F Meyer; T Aebischer
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more
  17 in total

Review 1.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells.

Authors:  Katharina Kranzer; Liane Söllner; Michael Aigner; Norbert Lehn; Ludwig Deml; Michael Rehli; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice.

Authors:  Lucinda J Thompson; Stephen J Danon; John E Wilson; Jani L O'Rourke; Nina R Salama; Stanley Falkow; Hazel Mitchell; Adrian Lee
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

4.  Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study.

Authors:  Li-Wei Chen; Chih-Yi Chien; Kai-Jie Yang; Sheng-Fong Kuo; Chih-Hung Chen; Rong-Nan Chien
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

Review 5.  Helicobacter pylori Infection and Risk of Lung Cancer: A Meta-Analysis.

Authors:  Pulikonda Mounika
Journal:  Lung Cancer Int       Date:  2013-02-28

6.  Histologic Findings and Inflammatory Reactions After Long-term Colonization of Helicobacter felis in C57BL/6 Mice.

Authors:  Ju Yup Lee; Nayoung Kim; Yoon Jeong Choi; Ryoung Hee Nam; Yoon Jin Choi; Yong Hwan Kwon; Kichul Yoon; Ji Hyung Suh; Seon Min Lee; Hye Seung Lee; Dong Ho Lee
Journal:  J Cancer Prev       Date:  2014-09

7.  The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based Study.

Authors:  Li-Wei Chen; Chih-Yi Chien; Chia-Wen Hsieh; Liang-Che Chang; Mei-Huei Huang; Wen-Yuan Huang; Sheng-Fong Kuo; Cheng-Hung Chien; Chih-Lang Lin; Rong-Nan Chien
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Anti-bacterial effects of enzymatically-isolated sialic acid from glycomacropeptide in a Helicobacter pylori-infected murine model.

Authors:  Hye-Ji Noh; Hong Bum Koh; Hee-Kyoung Kim; Hyang Hyun Cho; Jeongmin Lee
Journal:  Nutr Res Pract       Date:  2016-12-27       Impact factor: 1.926

9.  Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study.

Authors:  Li-Wei Chen; Fang-Ping Chen; Chia-Wen Hsieh; Sheng-Fong Kuo; Rong-Nan Chien
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

10.  Functional promoter -308G>A variant in tumor necrosis factor α gene is associated with risk and progression of gastric cancer in a Chinese population.

Authors:  Yan Hong; Zhijun Ge; Changrui Jing; Jun Shi; Xiao Dong; Fengying Zhou; Meilin Wang; Zhengdong Zhang; Weida Gong
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.